TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,688
|
2,440
|
1,836 |
| Financial expenses |
0
|
45
|
0 |
| Earnings before taxes |
137
|
90
|
147 |
| EBITDA |
134
|
41
|
147 |
| Total assets |
1,950
|
2,110
|
1,756 |
| Current assets |
1,825
|
1,985
|
1,586 |
| Current liabilities |
371
|
667
|
391 |
| Equity capital |
988
|
852
|
762 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.7%
|
40.4%
|
43.4% |
| Turnover per employee |
1,344
|
1,220
|
918 |
| Profit as a percentage of turnover |
5.1%
|
3.7%
|
8.0% |
| Return on assets (ROA) |
7.0%
|
6.4%
|
8.4% |
| Current ratio |
491.9%
|
297.6%
|
405.6% |
| Return on equity (ROE) |
13.9%
|
10.6%
|
19.3% |
| Change turnover |
248
|
604
|
-445 |
| Change turnover % |
10%
|
33%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.